1. Department of Advanced Biomedical Sciences, Federico II University, Via Pansini 5, 80131 Naples, Italy;
2. Center for Complex Networks Research and Department of Physics, Northeastern University, Boston, MA, USA;
3. Center for Cancer Systems Biology (CCSB) and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA;
4. Center for Network Science, Central European University, Budapest, Hungary;
5. Department of Medicine, and Division of Network Medicine, Brigham and Womens Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA;
6. Department of Cardiovascular Medicine, Humanitas Research Hospital and Humanitas University, Rozzano, Italy;
7. Institute of Genetic and Biomedical Research, National Research Council of Italy, Rozzano, Milan, Italy;
8. The Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, London, UK;
9. Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, 6229 ER Maastricht, The Netherlands;
10. Institute for Cardiovascular Regeneration, University Frankfurt, Frankfurt, Germany;
11. German Center for Cardiovascular Research (DZHK), RheinMain, Germany;
12. Experimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany;
13. The Hatter Cardiovascular Institute, University College London, London, UK;
14. The National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK;
15. Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, Singapore;
16. National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore;
17. Yong Loo Lin School of Medicine, National University Singapore, Singapore;
18. Departments of Medicine (Cardiology) and Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA;
19. Division of Heart and Lungs, Hubrecht Institute, University Medical Center Utrecht, Utrecht, The Netherlands;
20. UMC Utrecht Regenerative Medicine Center and Hubrecht Institute, Utrecht, The Netherlands;
21. Hatter Cardiovascular Research Institute, University of Cape Town, Cape Town, South Africa;
22. Neufeld Cardiac Research Institute, Tel-Aviv University, Tel-Aviv, Israel;
23. Tamman Cardiovascular Research Institute, Sheba Medical Center; Sheba Center for Regenerative Medicine, Stem Cell, and Tissue Engineering, Tel Hashomer, Israel;
24. Center of Aging Sciences and Translational Medicine – CESI-MeT, “G. d’Annunzio” University, Chieti, Italy; Institute of Cardiology, Department of Neurosciences, Imaging, and Clinical Sciences, “G. d’Annunzio” University, Chieti, Italy;
25. The Texas Heart Institute and Center for Cardiovascular Biology and Atherosclerosis Research, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA;
26. King's British Heart Foundation Centre, King's College London, London, UK;
27. Department of Cardiology, Institut MITOVASC, University of Angers, University Hospital of Angers, Angers, France;
28. Cardiology and UMC Utrecht Regenerative Medicine Center, University Medical Center Utrecht, Utrecht, The Netherlands;
29. Institute of Physiology, Justus Liebig University Giessen, Giessen, Germany;
30. Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany;
31. Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway;
32. Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary;
33. Cardiovascular Research Group, Department of Biochemistry, University of Szeged, Szeged, Hungary;
34. Pharmahungary Group, Szeged, Hungary